Rockefeller Capital Management’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRWD
AC
SCM
Rockefeller Capital Management's IRWD Position: Q2 2026 in Review
Rockefeller Capital Management held its Ironwood Pharmaceuticals (IRWD) position steady in Q2 2026 at 2,732 shares worth $11.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3959.
Rockefeller Capital Management first reported a position in IRWD in Q1 2018 and has held it in 18 quarters since. The position peaked at $51K in Q2 2018. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.
- Rockefeller Capital Management held 2,732 shares of Ironwood Pharmaceuticals worth $11.5K as of Q2 2026.
- Rockefeller Capital Management left its Ironwood Pharmaceuticals share count unchanged in Q2 2026.
- Ironwood Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3959 holding.
- Rockefeller Capital Management first reported a position in Ironwood Pharmaceuticals in Q1 2018 and has held it in 18 quarters since.
- Rockefeller Capital Management's Ironwood Pharmaceuticals position peaked at $51K in Q2 2018.
- 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.